๎๊ฒ์
๎๊ฒ์
๎
Emergent BioSolutions Inc
EBS๎ญ๊ด์ฌ ๋ชฉ๋ก์ ์ถ๊ฐ
6.800USD
-0.220-3.13%
์ข
๊ฐย 09-18 16:00๏ผET๏ผ
347.81M์๊ฐ์ด์ก
์์คP/E TTM
์ฅ์ธ ๊ฑฐ๋ย 19:00ย (ET)6.800USD-0.030-0.44%
์ฅ์ธ ๊ฑฐ๋ย 19:00ย (ET)Emergent BioSolutions Inc(EBS) ์์ต ์ฑ๊ณผ
๋ง์ง๋ง ์ ๋ฐ์ดํธ: Jun 30, 2026์๋ , Emergent BioSolutions Inc์ ๊ฐ์ฅ ์ข์ ์ฑ๊ณผ๋ฅผ ๋ธ ๋ถ๋ฌธ์ธ Commercial Product sales๋ 223.30M๋ฌ๋ฌ์ ์์ต์ ์ฌ๋ ธ์ต๋๋ค. Non-U.S Government์ด ๊ฐ์ฅ ํฐ ๊ธฐ์ฌ๋ฅผ ํ์ฌ, ์๋ ์ 403.20M๋ฌ๋ฌ์ ๋ฌํ์ต๋๋ค. ์ต๊ทผ ๋ถ๊ธฐ์ 2026-06-30๋ฅผ ๊ธฐ์ค์ผ๋ก Emergent BioSolutions Inc์ด MCM Product sales ๋ถ๋ฌธ์์ 168.00M๋ฌ๋ฌ์ ์์ต์ ๋ณด๊ณ ํ์ต๋๋ค. U.S.Government๊ฐ ๊ฐ์ฅ ๋์ ์์ต ๊ธฐ์ฌ๋ฅผ ํ์ฌ 157.10M๋ฌ๋ฌ๋ฅผ ๊ธฐ๋กํ์ต๋๋ค.
์ฌ์ ๋ณ
์์ต
๋น์จ
์ฐ๊ฐ๎ฎ
์ฐ๊ฐ
๋ถ๊ธฐ๋ณ
Commercial Product sales
MCM Product sales
Contracts and grants
Bioservices
Product sales, net
Contract development and manufacturing services
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Commercial Product sales
223.30M(50.76%)
398.90M(38.22%)
497.30M(47.39%)
386.60M(34.60%)
438.00M(24.70%)
--(--)
MCM Product sales
156.50M(35.58%)
509.80M(48.85%)
447.20M(42.62%)
579.60M(51.87%)
585.90M(33.03%)
--(--)
Contracts and grants
36.70M(8.34%)
30.00M(2.87%)
26.30M(2.51%)
41.40M(3.70%)
134.20M(7.57%)
115.10M(7.40%)
Bioservices
23.40M(5.32%)
104.90M(10.05%)
78.50M(7.48%)
109.90M(9.83%)
615.50M(34.70%)
--(--)
Product sales, net
--(--)
--(--)
--(--)
--(--)
--(--)
989.80M(63.64%)
Contract development and manufacturing services
--(--)
--(--)
--(--)
--(--)
--(--)
450.50M(28.96%)
์ง์ญ๋ณ
์์ต
๋น์จ
์ฐ๊ฐ๎ฎ
์ฐ๊ฐ
๋ถ๊ธฐ๋ณ
Non-U.S Government
U.S.Government
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Non-U.S Government
403.20M(91.66%)
633.10M(60.67%)
654.60M(62.38%)
634.90M(56.81%)
870.30M(49.07%)
566.90M(36.45%)
431.30M(39.00%)
U.S.Government
36.70M(8.34%)
410.50M(39.33%)
394.70M(37.62%)
482.60M(43.19%)
903.30M(50.93%)
988.50M(63.55%)
674.70M(61.00%)